Roger Abounader, MD, PhD
The American Cancer Society is backing the UVA Cancer Center’s efforts to nurture promising ideas from early career scientists that could lead to important breakthroughs in our understanding of cancer and improve our ability to treat it.
UVA’s National Cancer Institute-designated Comprehensive Cancer Center has received an ACS Institutional Research Grant that will provide seed funding for junior faculty to initiate research projects. The goal is to sustain early research so that the scientists can demonstrate the potential of their ideas and obtain additional grant funding to support their work in the long run.
To boost diversity in cancer research, the ACS award includes a special additional allocation for scientists from backgrounds typically underrepresented in research and medicine.
“The ACS-IRG funding has been and continues to be an essential mechanism for helping new cancer research faculty jumpstart their careers and generate new findings on the understanding and therapy of cancer for the future benefit of cancer patients,” said UVA’s Roger Abounader, MD, PhD, the principal investigator on the grant. Abounader is the Arthur and Margaret Ebbert Professor of Medical Science at the UVA School of Medicine and UVA Cancer Center’s Associate Director for Basic Research.
Read full press release in UVA Health Newsroom.